References
- Abbas, M., Kalia, S. (2016). Trends in non-melanoma skin cancer (basal cell carcinoma and squamous cell carcinoma) in Canada: A descriptive analysis of available data. J. Cutan. Med. Surg., 20 (2), 166–175.10.1177/120347541561010626458408
- Acton, S. E., Astarita, J. L., Malhotra, D., Lukacs-Kornek, V., Franz, B., Hess, P. R., Jakus, Z., Kuligowski, M., Fletcher, A. L., Elpek, K. G. et al. (2012). Podoplanin-rich stromal networks induce dendritic cell motility via activation of the C-type lectin receptor CLEC-2. Immunity,37 (2), 276–289.10.1016/j.immuni.2012.05.022355678422884313
- Arduino, P. G, Carrozzo, M., Pagano M., Broccoletti, R., Scully, C., Gandolfo, S. (2010). Immunohistochemical expression of basement membrane proteins of verrucous carcinoma of the oral mucosa. Clin. Oral Investig., 14 (3), 297–302.10.1007/s00784-009-0296-y19506920
- Argenziano, G., Zalaudek, I. (2007). Recent advances in dermoscopic diagnostic technologies. Eur. Oncol. Dis., 1 (2), 104–106.10.17925/EOH.2007.0.2.104
- Baars, S., Bauer, C., Szabowski, S., Hartenstein, B., Angel, P. (2015). Epithelial deletion of podoplanin is dispensable for re-epithelialization of skin wounds. Exp. Dermatol., 24 (10), 785–787.10.1111/exd.1278126121181
- Bartoš, V. (2019). Development of multiple-lesion basal cell carcinoma of the skin: A comprehensive review. Sisli Etfal Hastanesi tip bulteni, 53 (4), 323–328.
- Bartoš, V., Kullová, M. (2016). Basal cell carcinoma of the skin with mixed histomorphology: A comparative study. Cesk. Patol., 52 (4), 222–226.
- Carucci, J. A., Leffell, D. J. (2008). Basal cell carcinoma. In: Wolff, K., Goldsmith, L., Katz, S., Gilchrest, B., Paller, A. S., Leffel, D. Fitzpatrick’s Dermatology in General Medicine. 7th edition. McGraw Hill, New York, pp. 1036–1042.
- Cohen, P. R., Schulze, K. E., Nelson, B. R. (2005). Cutaneous carcinoma with mixed histology: A potential etiology for skin cancer recurrence and an indication for Mohs microscopically controlled surgical excision. South. Med. J., 98 (7), 740–747.10.1097/01.SMJ.0000166674.09383.EC16108247
- Costache, M., Georgescu, T. A., Oproiu, A. M., Costache, D., Naie, A., Sajin, M., Nica, A. E. (2018). Emerging concepts and latest advances regarding the etiopathogenesis, morphology and immunophenotype of basal cell carcinoma. Rom. J. Morphol. Embryol., 59 (2), 427–433.
- Crowson A. N. (2006). Basal cell carcinoma: Biology, morphology and clinical implications. Mod. Pathol., 19 (2), S127–S147.10.1038/modpathol.380051216446711
- Chuprov, I. N. (2008). Immunomorphological features of cutaneous basal-cell carcinoma. Voprosy onkologii, 54 (6), 715–719.
- Dandurand, M., Petit, T., Martel, P., Guillot, B., ANAES (2006). Management of basal cell carcinoma in adults Clinical practice guidelines. Eur. J. Dermatol., 16 (4), 394–401.
- De Vita, V., Di Leo, G., Fabbrocini, G., Liguori, C., Paolillo, A., Sommella, P. (2012). Statistical techniques applied to the automatic diagnosis of dermoscopic images. ACTA IMEKO, 1 (1), 7–18.10.21014/acta_imeko.v1i1.7
- Drucker, A. M., Adam, G. P., Rofeberg, V., Gazula, A., Smith, B., Moustafa, F., Weinstock, M. A., Trikalinos, T. A. (2018). Treatments of primary basal cell carcinoma of the skin: A systematic review and network meta-analysis. Ann. Intern. Med., 169 (7), 456–466.10.7326/M18-067830242379
- Elder, D. E., Massi, D., Scolyer, R. A., Willemze, R. (2018). WHO classification of skin tumours. WHO Classification of Tumours. 4th edn. Volume 11, pp. 27–33.
- El-Sayed, S. K., El-Sayed, G. D. A., Kamel, A. M., Al-Tramsy, A. A., Ateia, S. Y. (2020). Efficacy of dermoscopy in the diagnosis of different basal cell carcinoma subtypes. Egypt J. Dermatol. Venerol.,40 (1), 15–22.
- Emiroglu, N., Cengiz, F. P., Kemeriz, F. (2015). The relation between dermoscopy and histopathology of basal cell carcinoma. An. Bras. Dermatol., 90 (3), 351–356.10.1590/abd1806-4841.20153446451609026131865
- Enache, A. O, Pãtrascu, V., Simionescu, C. E, Ciurea, R. N., Vaduva, A., Stoica, L. (2019). Dermoscopy patterns and histopathological findings in nodular basal cell carcinoma-study on 68 cases. Curr. Health Sci. J., 45 (1), 116–122.
- Fang, M., Yuan, J., Peng, C., Li, Y. (2014). Collagen as a double-edged sword in tumour progression. Tumour Biol., 35 (4), 2871–2882.10.1007/s13277-013-1511-7398004024338768
- Ghafouri-Fard, S., Abbasi, A., Moslehi, H., Faramarzi, N., Taba Taba Vakili, S., Mobasheri, M. B., Modarressi, M. H. (2010). Elevated expression levels of testis-specific genes TEX101 and SPATA19 in basal cell carcinoma and their correlation with clinical and pathological features. Brit. J. Dermatol., 162 (4), 772–779.10.1111/j.1365-2133.2009.09568.x19886887
- Ghanadan, A., Abbasi, A., Rabet, M., Abdollahi, P., Abbasi, M. (2014). Characteristics of mixed type basal cell carcinoma in comparison to other BCC subtypes. Indian J. Dermatol., 59 (1), 56–59.
- Goh, B. K., Ang, P., Wu, Y. J., Goh, C. L. (2006). Characteristics of basal cell carcinoma amongst Asians in Singapore and a comparison between completely and incompletely excised tumours. Int. J. Dermatol., 45 (5), 561–564.10.1111/j.1365-4632.2004.02515.x16700792
- Khalesi, M., Whiteman, D. C., Doi, S. A., Clark, J., Kimlin, M. G, Neale, R. E. (2013). Cutaneous markers of photo-damage and risk of basal cell carcinoma of the skin: A meta-analysis. Cancer Epidemiol. Biomarkers Prev., 22 (9), 1483–1489.10.1158/1055-9965.EPI-13-042423833126
- Khlebnikova, A. N., Belova, L. A., Gurevich, L. E., Selezneva, E. V., Sedova, T. G. (2020). Specifics of type IV collagen expression in basal cell skin carcinoma [Хлебникова, А.Н., Белова, Л.А., Гуревич, Л.Е., Селезнева, Е.В., Cедова Т.Г. Особенности экспрессии коллагена IV типа в базалиоме кожи ] Almanac Clin. Med., 48 (2) (in Russian). https://www.almclinmed.ru/jour/article/view/1256 (accessed 25.03.2021).
- Kyrgidis, A., Vahtsevanos, K., Tzellos, T. G., Xirou, P., Kitikidou, K., Antoniades, K., Zouboulis, C. C., Triaridis, S. (2010). Clinical, histological and demographic predictors for recurrence and second primary tumours of head and neck basal cell carcinoma. A 1062 patient-cohort study from a tertiary cancer referral hospital. Eur. J. Dermatol., 20 (3), 276–282.
- Laikova, K. V., Oberemok, V. V., Krasnodubets, A. M., Gal’chinsky, N. V., Useinov, R. Z., Novikov, I. A., Temirova, Z. Z., Gorlov, M. V., Shved, N. A., Kumeiko, V. V. et al. (2019). Advances in the understanding of skin cancer: Ultraviolet radiation, mutations, and antisense oligonucleotides as anticancer drugs. Molecules (Basel, Switzerland), 24 (8), 1516.10.3390/molecules24081516651476530999681
- Lallas, A., Apalla, Z., Ioannides, D., Argenziano, G., Castagnetti, F., Moscarella, E., Longo, C., Palmieri, T., Ramundo, D., Zalaudek, I. (2015). Dermoscopy in the diagnosis and management of basal cell carcinoma. Future Oncol., 11 (22), 2975–2984.10.2217/fon.15.19326450622
- Lallas, A., Argenziano, G., Zendri, E., Moscarella, E., Longo, C., Grenzi, L., Pellacani, G., Zalaudek, I. (2013). Update on non-melanoma skin cancer and the value of dermoscopy in its diagnosis and treatment monitoring. Expert Rev. Anticancer. Ther., 13 (5), 541–558.10.1586/era.13.3823617346
- Lammers, G., Verhaegen, P., Ulrich, M., Schalkwijk, J., Middelkoop, E., Weiland, D., Daamen W. (2011). An overview of methods for the in vivo evaluation of tissue-engineered skin constructs. Tissue Eng. Part B Rev., 17 (1), 33–55.10.1089/ten.teb.2010.0473
- Longo, C., Lallas, A., Kyrgidis, A., Rabinovitz, H., Moscarella, E., Ciardo, S., Zalaudek, I., Oliviero, M., Losi, A., Gonzalez, S., Guitera, P., Piana, S., Argenziano, G., Pellacani, G. (2014). Classifying distinct basal cell carcinoma subtype by means of dermatoscopy and reflectance confocal microscopy. J. Amer. Acad. Dermatol.,71 (4), 716–724.e1.10.1016/j.jaad.2014.04.06724928707
- Mackiewicz-Wysocka, M., Bowszyc-Dmochowska, M., Strzelecka-Węklar, D., Dañczak-Pazdrowska, A., Adamski, Z. (2013). Basal cell carcinoma — diagnosis. Contemp. Oncol.(Poznan), 17 (4), 337–342.
- Madan, V., Lear, J. T. (2016). Basal cell carcinoma. In: Griffiths, C. E., Barker, J., Bleaker, T., Chalmer, R., Creamer, D. (eds.) Rook’s Textbook of Dermatology. 9th edn. John Willy & Sons, West Sussex, UK, pp. 141–146.
- Marasą, L., Marasą, S., Sciancalepore, G. (2008). Collagen IV, laminin, fibronectin, vitronectin. Comparative study in basal cell carcinoma. Correlation between basement membrane molecules expression and invasive potential. G. Ital. Dermatol. Venereol., 143 (3), 169–173.
- Marzuka, A. G., Book, S. E. (2015). Basal cell carcinoma: Pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management. Yale. J. Biol. Med., 88 (2), 167–179.
- Mehta, K. S., Mahajan, V. K., Chauhan, P. S., Sharma, A. L., Sharma, V., Abhinav, C., Khatri, G., Prabha, N., Sharma, S., Negi, M. (2012). Meta-static basal cell carcinoma: A biological continuum of basal cell carcinoma? Case Rep. Dermatol. Med., 2012, 157187.
- Miyake, M., Hori, S., Morizawa, Y., Tatsumi, Y., Toritsuka, M., Ohnishi, S., Shimada, K., Furuya, H., Khadka, V. S., Deng, Y. et al. (2017). Collagen type IV alpha 1 (COL4A1) and collagen type XIII alpha 1 (COL13A1) produced in cancer cells promote tumour budding at the invasion front in human urothelial carcinoma of the bladder. Oncotarget.,8 (22), 36099–36114.10.18632/oncotarget.16432548264128415608
- Muzic, J. G., Schmitt, A. R., Wright, A. C., Alniemi, D. T., Zubair, A. S., Olazagasti Lourido, J. M., Sosa Seda, I. M., Weaver, A. L., Baum, C. L. (2017). Incidence and trends of basal cell carcinoma and cutaneous squamous cell carcinoma: A population-based study in Olmsted County, Minnesota, 2000 to 2010. Mayo Clinic Proc.,92 (6), 890–898.10.1016/j.mayocp.2017.02.015
- Neinaa, Y., El-Ashmawy, A. A., Alshenawy, H. A., Dorgham, W. L. (2020). The prognostic value of podoplanin expression in nonmelanoma skin cancers: Correlation with lymphatic vessel density. Amer. J. Dermatopathol., 42 (6), 432–438.10.1097/DAD.0000000000001561
- Nolan, G. S., Wormald, J. C. R., Kiely, A. L., Totty, J. P., Jain, A. (2020). Global incidence of incomplete surgical excision in adult patients with non-melanoma skin cancer: Study protocol for a systematic review and meta-analysis of observational studies. Syst. Rev., 9, 83.10.1186/s13643-020-01350-5
- Okuboyejo, D. A., Olugbara, O. O. (2018). A review of prevalent methods for automatic skin lesion diagnosis. Open Dermatol. J., 12 (1), 14–53.10.2174/187437220181201014
- Paoli, J., Gyllencreutz, J. D., Fougelberg, J., Backman, E. J., Modin, M., Polesie, S., Zaar, O. (2019). Nonsurgical options for the treatment of basal cell carcinoma. Dermatol. Pract. Concept.,9 (2), 75–81.10.5826/dpc.0902a01
- Peterson, S. C., Eberl, M., Vagnozzi, A. N., Belkadi, A., Veniaminova, N. A., Verhaegen, M. E., Bichakjian, C. K., Ward, N. L., Dlugosz, A. A., Wong, S. Y. (2015). Basal cell carcinoma preferentially arises from stem cells within hair follicle and mechanosensory niches. Cell Stem Cell, 16 (4), 400–412.10.1016/j.stem.2015.02.006
- Popadič, M. (2014). Statistical evaluation of dermoscopic features in basal cell carcinomas. Dermatol. Surg., 40 (7), 718–724.
- Puig, S., Cecilia, N., Malvehy, J. (2012). Dermoscopic criteria and basal cell carcinoma. G. Ital. Dermatol. Venereol.,147 (2), 135–140.
- Roldán-Marín, R., Leal-Osuna, S., Lammoglia-Ordiales, L., Toussaint-Caire, S. (2014). Infundibulocystic basal cell carcinoma: dermoscopic findings and histologic correlation. Dermatol. Pract. Concept.,4 (3), 51–54.10.5826/dpc.0403a09
- Rowe, R. G., Weiss, S. J. (2008). Breaching the basement membrane: Who, when and how? Trends Cell Biol., 18 (11), 560–574.
- Rubin, A. I., Chen, E. H., Ratner, D. (2005). Basal-cell carcinoma. New Engl. J. Med.,353 (21), 2262–2269.10.1056/NEJMra044151
- Russo, T., Piccolo, V., Lallas, A., Argenziano, G. (2016). Recent advances in dermoscopy. F1000Res., 5, F1000 Faculty Rev–184.10.12688/f1000research.7597.1
- Sexton, M., Scotto, J., Kopf, A. W., Urbach, F. (1974). Non-melanoma skin cancer among Caucasians in four areas of the United States. Cancer, 34, 1333–1338.10.1002/1097-0142(197410)34:4<1333::AID-CNCR2820340447>3.0.CO;2-A
- Tanjore, H., Kalluri, R. (2006). The role of type IV collagen and basement membranes in cancer progression and metastasis. Amer. J. Pathol., 168 (3), 715–717.10.2353/ajpath.2006.051321160653016507886
- Telfer, N. R., Colver, G. B., Morton, C. A., British Association of Dermatologists (2008). Guidelines for the management of basal cell carcinoma. Brit. J. Dermatol., 159 (1), 35–48.10.1111/j.1365-2133.2008.08666.x18593385
- Verduzco-Martínez, A. P., Quiñones-Venegas, R., Guevara-Gutiérrez, E., Tlacuilo-Parra, A. (2013). Correlation of dermoscopic findings with histopathologic variants of basal cell carcinoma. Int. J. Dermatol., 52 (6), 718–721.10.1111/j.1365-4632.2012.05816.x23679878
- Wadhera, A., Fazio, M., Bricca, G., Stanton, O. (2006). Metastatic basal cell carcinoma: A case report and literature review. How accurate is our incidence data? Dermatol. Online J., 12 (5), 7.
- Wicki, A., Lehembre, F., Wick, N., Hantusch, B., Kerjaschki, D., Christofori, G. (2006). Tumour invasion in the absence of epithelial– mesenchymal transition: Podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell, 9 (4), 261–272.10.1016/j.ccr.2006.03.01016616332
- Wicki, A., Christofori, G. (2007). The potential role of podoplanin in tumour invasion. Brit. J. Cancer, 96 (1), 1–5.10.1038/sj.bjc.6603518236021317179989
- Wojciechowska-Zdrojowy, M., Szepietowski, J. C., Matusiak, Ł., Dzięgiel, P., Puła, B. (2016). Expression of podoplanin in non-melanoma skin cancers and actinic keratosis. Anticancer Res., 36 (4), 1591–1597.
- Wozniak-Rito, A., Zalaudek, I., Rudnicka, L. (2018). Dermoscopy of basal cell carcinoma. Clin. Exp. Dermatol., 43 (3), 241–247.10.1111/ced.1338729341291
- Zalaudek, I., Kreusch, J., Giacomel, J., Ferrara, G., Catricalą, C., Argenziano, G. (2010). How to diagnose nonpigmented skin tumours: A review of vascular structures seen with dermoscopy. Part I. Melanocytic skin tumours. J. Amer. Acad. Dermatol., 63 (3), 361–376.